WHO ICTRP trial
Reversal of pipecuronium-induced neuromuscular blockade with Sugammadex during…
CTIS2025-521375-31-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2025-521375-31-00 |
|---|---|
| Public title | Reversal of pipecuronium-induced neuromuscular blockade with Sugammadex during sevoflurane anesthesia: a drug safety randomised controlled trial |
| Scientific title | - AITT 2025/2 |
| Primary sponsor | University Of Debrecen |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes |
| Countries | Hungary |
| Conditions | Anesthesia and Analgesia, Patient safety MedDRA version: 21.1Level: LLTClassification code: 10029313Term: Neuromuscular block Class: 10029205;Therapeutic area: Not possible to specify |
| Registration date | Mar 21, 2025 |
| Target size | 80 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: